Cargando…

A risk stratification model based on four novel biomarkers predicts prognosis for patients with renal cell carcinoma

BACKGROUND: Accurate prediction of the prognosis of RCC using a single biomarker is challenging due to the genetic heterogeneity of the disease. However, it is essential to develop an accurate system to allow better patient selection for optimal treatment strategies. ARL4C, ECT2, SOD2, and STEAP3 ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kubota, Shigehisa, Yoshida, Tetsuya, Kageyama, Susumu, Isono, Takahiro, Yuasa, Takeshi, Yonese, Junji, Kushima, Ryoji, Kawauchi, Akihiro, Chano, Tokuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584101/ https://www.ncbi.nlm.nih.gov/pubmed/33092599 http://dx.doi.org/10.1186/s12957-020-02046-9

Ejemplares similares

Abundance of TRAIL attenuated by HIF2α and c-FLIP affects malignancy in renal cell carcinomas
por: Isono, Takahiro, et al.
Publicado: (2018)

Therapeutic inhibition of mitochondrial function induces cell death in starvation-resistant renal cell carcinomas
por: Isono, Takahiro, et al.
Publicado: (2016)

Mechanisms of Tumor Growth Inhibition by Depletion of γ-Glutamylcyclotransferase (GGCT): A Novel Molecular Target for Anticancer Therapy
por: Kageyama, Susumu, et al.
Publicado: (2018)

Glucose Deprivation Induces G2/M Transition-Arrest and Cell Death in N-GlcNAc(2)-Modified Protein-Producing Renal Carcinoma Cells
por: Isono, Takahiro, et al.
Publicado: (2014)

Abundance of mitochondrial superoxide dismutase is a negative predictive biomarker for endometriosis-associated ovarian cancers
por: Amano, Tsukuru, et al.
Publicado: (2019)

Transcriptome analysis of a dog model of congestive heart failure shows that collagen-related 2-oxoglutarate-dependent dioxygenases contribute to heart failure
por: Isono, Takahiro, et al.
Publicado: (2022)

Differences in the Central Energy Metabolism of Cancer Cells between Conventional 2D and Novel 3D Culture Systems
por: Ikari, Ryo, et al.
Publicado: (2021)

Long-Term Prostate-Specific Antigen Response on a Low-Dose Cabazitaxel Regimen for Metastatic Castration-Resistant Prostate Cancer: A Case Report
por: Kubota, Shigehisa, et al.
Publicado: (2021)

Androgen receptor axis-targeted agents are not superior to conventional hormonal therapy for treatment of metastatic prostate cancer
por: Wada, Akinori, et al.
Publicado: (2022)

Study of Global Transcriptional Changes of N-GlcNAc(2) Proteins-Producing T24 Bladder Carcinoma Cells under Glucose Deprivation
por: Isono, Takahiro, et al.
Publicado: (2013)

Correction: Study of Global Transcriptional Changes of N-GlcNAc(2) Proteins-Producing T24 Bladder Carcinoma Cells under Glucose Deprivation
por: Isono, Takahiro, et al.
Publicado: (2013)

Metastatic Prostatic Ductal Adenocarcinoma Successfully Treated with Docetaxel Chemotherapy: A Case Report
por: Fujiwara, Ryo, et al.
Publicado: (2015)

Biomarkers to predict prognosis and response to checkpoint inhibitors
por: Yuasa, Takeshi, et al.
Publicado: (2017)

The location of the bladder neck in postoperative cystography predicts continence convalescence after radical prostatectomy
por: Kageyama, Susumu, et al.
Publicado: (2018)

Prognostic nutritional index of early post-pembrolizumab therapy predicts long-term survival in patients with advanced urothelial carcinoma
por: Kageyama, Susumu, et al.
Publicado: (2022)

Recent advances in medical therapy for metastatic urothelial cancer
por: Yuasa, Takeshi, et al.
Publicado: (2018)

High Expression of Human Uroplakin Ia in Urinary Bladder Transitional Cell Carcinoma
por: Kageyama, Susumu, et al.
Publicado: (2002)

Efficient Prostate Cancer Therapy with Tissue-Specific Homing Peptides Identified by Advanced Phage Display Technology
por: Wada, Akinori, et al.
Publicado: (2019)

Case Report: A Case of Trimethoprim/Sulfamethoxazole-Triggered Hypotensive Shock: Cytokine Release Syndrome Related to Immune Checkpoint Inhibitors and Drug-Induced Hypersensitivity Syndrome
por: Urasaki, Tetsuya, et al.
Publicado: (2021)

Prediction of intravesical recurrence of non-muscle-invasive bladder cancer by evaluation of intratumoral Foxp3(+) T cells in the primary transurethral resection of bladder tumor specimens
por: Murai, Ryosuke, et al.
Publicado: (2018)

Relationship of B7-H3 expression in tumor cells and tumor vasculature with FOXP3+ regulatory T cells in renal cell carcinoma
por: Inamura, Kentaro, et al.
Publicado: (2019)

Denosumab: a new option in the treatment of bone metastases from urological cancers
por: Yuasa, Takeshi, et al.
Publicado: (2012)

Prior administration of a non-steroidal anti-androgen failed to prevent the flare-up caused by a luteinizing hormone-releasing hormone agonist in a patient with metastatic prostate cancer
por: Uehara, Sho, et al.
Publicado: (2015)

Effectiveness and safety profile of pembrolizumab for metastatic urothelial cancer: A retrospective single‐center analysis in Japan
por: Fujiwara, Motohiro, et al.
Publicado: (2021)

A radiological complete response to pembrolizumab in a patient with metastatic upper urinary tract urothelial cancer and Lynch syndrome
por: Oki, Ryosuke, et al.
Publicado: (2022)

Improvement of renal function by changing the bone-modifying agent from zoledronic acid to denosumab
por: Yamasaki, Mutsushi, et al.
Publicado: (2016)

Pharmacokinetic/Pharmacodynamic Analysis of a Hemodialyzed Patient Treated with 25 mg of Sunitinib
por: Noda, Satoshi, et al.
Publicado: (2012)

A case of gastric metastasis from renal cell cancer during the sequential targeted therapy
por: Uehara, Sho, et al.
Publicado: (2017)

Diagnostic performance of a computer-assisted diagnosis system for bone scintigraphy of newly developed skeletal metastasis in prostate cancer patients: search for low-sensitivity subgroups
por: Koizumi, Mitsuru, et al.
Publicado: (2017)

A case of sequential medical therapy for advanced ureteral cancer in Li–Fraumeni syndrome
por: Une, Minami, et al.
Publicado: (2023)

Unusual metastasis from renal cell cancer after partial nephrectomy and sequential targeted therapy
por: Yasuoka, Shotaro, et al.
Publicado: (2021)

Long-term complete response of antiandrogen withdrawal syndrome in a patient with metastatic prostate cancer: A case report
por: Sano, Masayuki, et al.
Publicado: (2016)

Pembrolizumab for a patient with metastatic castration‐resistant prostate cancer with microsatellite instability‐high
por: Fujiwara, Motohiro, et al.
Publicado: (2020)

De novo large‐cell neuroendocrine carcinoma of the prostate: A case report and literature review
por: Fukagawa, Eri, et al.
Publicado: (2022)

Clinical outcome of patients with pancreatic metastases from renal cell cancer
por: Yuasa, Takeshi, et al.
Publicado: (2015)

Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma
por: Amano, Tsukuru, et al.
Publicado: (2021)

Organ-specific and tumor-size-dependent responses to sunitinib in clear cell renal cell carcinoma
por: Tsuchiya, Norihiko, et al.
Publicado: (2014)

Syndrome of inappropriate antidiuretic hormone secretion as a side effect of chemotherapy for testicular cancer: A case report
por: Maeda, Koki, et al.
Publicado: (2019)

Gamma-Glutamylcyclotransferase: A Novel Target Molecule for Cancer Diagnosis and Treatment
por: Kageyama, Susumu, et al.
Publicado: (2015)

Preparation of Mouse Monoclonal Antibody for RB1CC1 and Its Clinical Application
por: Hama, Yusuke, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_g9dt4op47cbfhcl0lm38p44qt5